Objectives: Germline mutations in cancer susceptibility genes other than BRCA1 and BRCA2 (BRCA1/2)
are found in approximately 6% of women with ovarian, fallopian tube, or primary peritoneal
cancer. Our objective was to sequence BRCA1/2-negative ovarian cancer patients with
a family history of ovarian or breast cancer to identify inherited mutations that
may explain the familial risk.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gynecologic OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2014 Published by Elsevier Inc.
